+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 7 Actively Recruiting clinical trials

B

Actively Recruiting

Researchers are collecting real-world data to evaluate the effectiveness and safety of new systemic treatments such as biologics and Janus kinase inhibitors in patients with atopic dermatitis. The BioDay Registry also studies the impact of these treatments on related allergic conditions like food allergies, asthma, and conjunctivitis. This observational registry gathers information from multiple centers to better understand treatment outcomes in daily clinical practice. Participants include both adults and children receiving new systemic therapies for their atopic dermatitis. There is no assigned treatment in the study since it is observational instead, data is collected as patients receive their prescribed medications. The registry includes modules for atopic comorbidities and monitors patients over time to capture the effects of treatment in routine care. Participants will provide data through questionnaires and clinical assessments at multiple timepoints, including baseline, 16 weeks, 1 year, 2 years, and annually up to 5 years. Researchers track changes in disease symptoms, side effects, drug continuation rates, laboratory results, comorbid conditions, and any dose adjustments. This long-term follow-up aims to improve understanding of treatment safety and effectiveness in everyday settings.

Age: 0Years +All Genders
14 locations
T

Actively Recruiting

This research aims to evaluate individualized thrombosis prevention after total hip or knee replacement surgery. Despite standard blood thinner treatment given to all patients to prevent venous thromboembolism VTE, some still develop clots while others experience bleeding. The study investigates whether customizing the type and duration of blood thinner treatment based on each patients medical history can reduce both clotting and bleeding risks compared to the standard uniform approach. Participants are grouped by their predicted VTE risk using the TRiPplasty score into low, intermediate, or high risk. Low-risk patients are randomized to receive either standard prophylaxis or a shortened treatment only during hospital stay. High-risk patients are randomized to receive standard treatment or a higher dose for six weeks. Intermediate-risk patients are observed without treatment changes. Blood thinners used include types of LMWH or DOACs given according to local standards, with dosing timing specified after surgery. Participants complete four questionnaires one before surgery and follow-ups at 2 weeks, 6 weeks, and 3 months post-surgery to report any VTE or bleeding events. An additional questionnaire is sent one year after surgery if certain complications occurred, assessing quality of life and joint function. No extra hospital visits are required. The main outcomes measured are symptomatic VTE and major bleeding within 90 days post-surgery, along with other health and quality of life measures up to one year.

Age: 18Years +All GendersPhase 4
13 locations
E

Actively Recruiting

This research focuses on complicated appendicitis CA, a severe form of appendicitis involving gangrenous or perforated tissue andor abscess formation, which remains a common cause of emergency surgery. Despite laparoscopic appendectomy being the preferred surgical treatment and the use of postoperative intravenous antibiotics, the occurrence of intra-abdominal abscesses IAA remains significant, affecting up to 24% of patients and causing readmissions, prolonged hospital stays, and increased healthcare costs. The study aims to assess whether laparoscopic antibiotic peritoneal lavage can reduce the incidence of IAA in patients with CA. Participants undergo laparoscopic appendectomy for confirmed complicated appendicitis and are randomly assigned to receive either a laparoscopic antibiotic peritoneal lavage using a gentamicinclindamycin solution for 3 minutes after surgery or no additional intervention. This randomized, double-blind trial compares these two approaches to determine the effect of the antibiotic lavage on infection control following surgery. During the study, patients are monitored for up to 30 days to track the occurrence of intra-abdominal abscesses as the primary outcome. Secondary assessments include wound infections, treatments required for abscesses, microbial cultures, operating time, readmission and reoperation rates, length of hospital stay, adverse events, surgical complications, mortality, quality of life, postoperative consultations, and healthcare costs over a 90-day follow-up period. The study provides detailed tracking of clinical outcomes to evaluate the impact of antibiotic lavage on recovery and complications after surgery.

Age: 8Years +All GendersPhase 3
11 locations
S

Actively Recruiting

Researchers are exploring ways to preserve the rectum in patients with rectal cancer who show a good clinical response after neoadjuvant chemoradiation. This phase II feasibility study compares two local treatment approaches contact x-ray brachytherapy versus extending the waiting period with or without local excision. The goal is to determine how often organ preservation can be achieved and to optimize treatment strategies for patients with a near-complete response or small residual tumor. The study includes two experimental groups. In one group, contact x-ray brachytherapy is delivered as three 30 Gy fractions to the tumor within 14 weeks after completing chemoradiation, with two-week intervals between doses. Patients are monitored every three months afterward. The other group extends the waiting interval by 6 to 8 weeks after the initial response evaluation, with additional assessments to check for tumor response. Patients showing complete response enter a watch-and-wait approach, while those with small remaining lesions may receive local excision, followed by risk-based recommendations for further treatment. Participants undergo regular clinical, radiological, and endoscopic assessments to monitor tumor response and detect any disease progression. The primary outcome is the rate of successful organ preservation one year after randomization. Secondary outcomes include treatment-related toxicity, postoperative complications, bowel and bladder function, quality of life, tumor regrowth, disease-free survival, and overall survival measured up to five years. An intensive follow-up program supports early detection of recurrence and timely surgical intervention if needed.

Age: 18Years +All GendersPhase Not Applicable
7 locations
R

Actively Recruiting

This research aims to develop and evaluate a personalized, patient-centered follow-up program for people who have had surgery to treat colorectal carcinoma without metastasis. The study focuses on improving quality of life and reducing stress by moving much of the follow-up care from hospital visits to the patients home. The program will be compared to standard follow-up care over 36 months to see if it maintains quality of life while decreasing the number of hospital appointments. The study involves home-based monitoring that includes regular blood tests to check carcinoembryonic antigen CEA levels using an automatic capillary blood withdrawal device every six months for the first two years and annually thereafter. Vital signs are measured quarterly during the first two years and every six months after that using a remote monitoring system. Quality of life is assessed through questionnaires at the same intervals. One in-hospital medical imaging exam is scheduled one year after surgery according to national guidelines. The follow-up is aligned with Dutch national recommendations and adapts to any updates. Participants will take part for 36 months, during which their quality of life and number of hospital visits will be monitored. Researchers will collect blood samples, vital signs, and questionnaire responses remotely from home, with one hospital imaging visit after one year. The primary outcomes measured are health-related quality of life using the EQ 5D-5L questionnaire and the count of in-hospital appointments. This approach aims to provide a fuller picture of patients health while reducing hospital stress and visits.

Age: 21Years +All GendersPhase Not Applicable
5 locations
P

Actively Recruiting

Researchers are investigating how various factors beyond tumor stage, such as biochemical, histopathological, genomic, environmental, and clinical characteristics, affect the outcomes of patients diagnosed with colorectal cancer CRC, small bowel cancer, and anal cancer. This observational study aims to collect detailed information from diagnosis through long-term follow-up to better understand prognosis and treatment effects in both early and late-stage cancers. The study addresses the gap between clinical trial populations and real-world patients by including a broader patient group treated in general practice. Participants will be followed prospectively from their initial diagnosis until death. Data collection includes medical history, clinical parameters, imaging, pathology, tumor details, treatments, hospital stays, interventions, and adverse events. With separate consent, patient-reported quality of life and work ability information will also be gathered. Additionally, biological samples obtained during routine care may be collected for further observational and molecular research. This cohort serves as a platform for evaluating new interventions through a Trials within Cohorts TwiCs design. Throughout up to ten years of follow-up, participants will undergo assessments of progression-free survival, disease-free survival, overall survival, and serious adverse events. Quality of life and work ability are assessed at intervals of 3, 6, 12, 24, 36, and 48 months. This extensive data collection supports a wide range of research aims including prognostic studies, molecular analyses, comparisons of new treatments, and health policy evaluations. The study provides a comprehensive view of treatment outcomes and patient experiences in everyday clinical settings.

Age: 18Years +All Genders
70 locations
E

Actively Recruiting

Researchers are investigating how training affects oxidative stress and daily life functions in people with knee osteoarthritis. This study evaluates whether supervised exercise therapy or walking 6000 steps per day can improve pain, physical function, and biological markers of cellular stress. The trial aims to strengthen muscles around the knee and enhance overall fitness to support better daily activities. Participants are randomly assigned to one of two groups one group receives supervised training twice weekly for six weeks guided by a physical therapist focusing on strength and fitness, while the other group walks 6000 steps daily on their own for the same six-week period. The interventions are designed to compare the effects of structured exercise versus daily walking. Before and after the six-week period, participants provide small capillary blood samples via finger prick and complete questionnaires to assess pain and specific knee complaints. Researchers measure pain scores, physical function, and oxidative stress blood markers at these time points. The study runs from screening through six weeks of intervention with all visits and assessments planned within this timeframe.

Age: 18Years +All GendersPhase Not Applicable
1 location